Is E2 Luteal Support in High Responder Long Gn-RH Agonist ICSI Cycles Detrimental to Cycle Outcome ? A Randomized Clinical Trial
This clinical trial investigates the impact of adding estradiol (E2) to progesterone (P4) for luteal phase support in high ovarian responders undergoing ICSI. The study aims to clarify conflicting evidence regarding the efficacy of E2 in improving pregnancy outcomes.
Indication: IVF
Modality: small molecule
Target: Luteal phase support in high responder ICSI cycles
Sponsor: Mansoura Integrated Fertility Center
Source URL: ClinicalTrials.gov
Source updated: Jun 21, 2022
Ingested: May 30, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Luteal phase support in high responder ICSI cycles
View original source fields
Condition raw: IVF
Condition normalized: IVF
Modality raw: IVF
Modality normalized: small molecule
Target raw: Luteal phase support in high responder ICSI cycles
Target normalized: Luteal phase support in high responder ICSI cycles